Candidate Follow Up - Professor Richard Kirk 2023
Professor Richard Kirk
MA FRCP FRCPCH
×
Transplant
Heart Transplant
Evaluation
Listing Criteria
Pediatric
Adult
Sensitized Candidates
Candidate Follow Up
Donor Offer
Peritransplant Issues
Transplant Week 1
Transplant Follow Up
Rejection
Graft Failure
Drug Interactions
Dallas Transplant Guidelines
Lung Transplant
Evaluation
Listing Criteria
Candidate Follow Up
Donor Offer
Peritransplant Issues
Transplant Week 1
Transplant FU
Rejection
Spirometry
Drug Interactions
Multi-Organ Transplant
Introduction
Heart-Lung
Heart or Lung plus Kidney
Heart or Lung plus Liver
Immunosuppression
Patient Information
Immunology
Introduction
Background
Overview
ABO Grouping
HLA Structure and Function
Cross Matching
T cell Biology
B cell Biology
Plasma Cells and Antibodies
Innate Immunity
Accommodation_Tolerance
Immunosuppression
Immunosuppression
Adverse Effects
Drug Interactions
Adherence
Transplant Challenges
ABO Mismatch
HLA Mismatch
Post Transplant DSA
Rejection
Conclusion
Decision Making
Vaccination Schedules - CDC
Heart Failure
Introduction
Assessment
Investigation
Management
Acute Care
Transition Care
Chronic Care
Comorbidities
Medications
ICD Indications
Special Conditions
Myocarditis
Fontan Failure
AHA HF Guidelines
Introduction
Staging and Classification
Management for at risk HF
HFrEF
HRmrEF
HFimpEF
HFpEf
ICD & CRT
PAH
Introduction
Definition
Diagnostic Algorithm
Risk Assessment
Treatment
Treatment - CHD
Medications
Career
Team Building
Charity
Medical
The DOAM Project
Publications
Presentations
Search
×
Transplant
Heart Transplant
Evaluation
Listing Criteria
Pediatric
Adult
Sensitized Candidates
Candidate Follow Up
Donor Offer
Peritransplant Issues
Transplant Week 1
Transplant Follow Up
Rejection
Graft Failure
Drug Interactions
Dallas Transplant Guidelines
Lung Transplant
Evaluation
Listing Criteria
Candidate Follow Up
Donor Offer
Peritransplant Issues
Transplant Week 1
Transplant FU
Rejection
Spirometry
Drug Interactions
Multi-Organ Transplant
Introduction
Heart-Lung
Heart or Lung plus Kidney
Heart or Lung plus Liver
Immunosuppression
Patient Information
Immunology
Introduction
Background
Overview
ABO Grouping
HLA Structure and Function
Cross Matching
T cell Biology
B cell Biology
Plasma Cells and Antibodies
Innate Immunity
Accommodation_Tolerance
Immunosuppression
Immunosuppression
Adverse Effects
Drug Interactions
Adherence
Transplant Challenges
ABO Mismatch
HLA Mismatch
Post Transplant DSA
Rejection
Conclusion
Decision Making
Vaccination Schedules - CDC
Heart Failure
Introduction
Assessment
Investigation
Management
Acute Care
Transition Care
Chronic Care
Comorbidities
Medications
ICD Indications
Special Conditions
Myocarditis
Fontan Failure
AHA HF Guidelines
Introduction
Staging and Classification
Management for at risk HF
HFrEF
HRmrEF
HFimpEF
HFpEf
ICD & CRT
PAH
Introduction
Definition
Diagnostic Algorithm
Risk Assessment
Treatment
Treatment - CHD
Medications
Career
Team Building
Charity
Medical
The DOAM Project
Publications
Presentations
Search
Go to content
Pulmonary Transplantation
Evaluation
Listing
Candidate FU
Donor Offer
Peri Tx Issues
Transplant Week 1
Transplant FU
Rejection
Drug Interactions
Candidate Follow Up
Last Updated: September 2022
Back to content
To use this website you must enable JavaScript.